Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer-Reference-Cited by-同舟云学术

Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer

Published:2004-03-22 Issue:1 Volume:86 Page:16-21
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Manuel del Casar José,Vizoso Francisco José,Abdel-Laa Omar,Sanz Lourdes,Martín Aranzazu,Daniela Corte María,Bongera Miguel,García Muñiz José Luis,Fueyo Antonio

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference30 articles.

1. Tumor-associated proteases and inhibitors in gastric cancer: Analysis of prognostic impact and individual risk protease patterns;Allgayer;Clin Exp Metastasis,1998

2. Cathepsin D and breast cancer;Westley;Eur J Cancer,1996

3. Cathepsin D is membrane associate in macrophage endosomes;Diment;J Biol Chem,1988

4. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells;Saftig;EMBO J,1995

5. Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?;Rochefort;J Cell Biochem,1987

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SEPROGADIC – serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy;Scientific Reports;2018-11-15

2. Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays;International Journal of Proteomics;2012-08-07

3. The dilemma: Does tissue expression of cathepsin D reflect tumor malignancy? The question: Does the assay truly mirror cathepsin D mis-function in the tumor?;Cancer Biomarkers;2010-10-22

4. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance;Journal of Cancer Research and Clinical Oncology;2007-07-13

5. Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors;PROTEOMICS;2005-05